BeyondSpring BYSI
NASDAQ BYSI
$0.77 +0.16 (+25.70%)
At close: Sep 10, 2026 · 4:00 PM EDT

BeyondSpring (BYSI) Non Operating Interest Expenses (2019 - 2021)

BeyondSpring's (BYSI) quarterly Non Operating Interest Expenses came in at $21000.0 in Q4 2021, down 4.55% year-over-year from $22000.0 in Q4 2020, and up 5.0% quarter-over-quarter from $20000.0 in Q3 2021.

Analysis

BeyondSpring (BYSI) Non Operating Interest Expenses (2019 - 2021) Analysis & Trends

BeyondSpring has disclosed Non Operating Interest Expenses across 3 years of filings, most recently posting $21000.0 for Q4 2021.

  • In Q4 2021, Non Operating Interest Expenses fell 4.55% year-over-year to $21000.0; the TTM figure through Dec 2021 stood at $87000.0 (up 2.35% YoY), while the FY2022 annual figure was $17000.0, down 80.46% from the prior year.
  • Non Operating Interest Expenses came in at $21000.0 for Q4 2021 at BeyondSpring, up from $20000.0 in the prior quarter.
  • In the past five years, Non Operating Interest Expenses ranged from a high of $103000.0 in Q2 2019 to a low of $20000.0 in Q4 2019.
  • Average Non Operating Interest Expenses over 3 years is $31500.0, with a median of $21500.0 recorded in 2020.
  • Year-over-year, Non Operating Interest Expenses slumped 79.61% in 2020 and climbed 14.29% in 2021.
  • Over 3 years, Non Operating Interest Expenses stood at $20000.0 in 2019, then gained by 10.0% to $22000.0 in 2020, then fell by 4.55% to $21000.0 in 2021.
  • Per Business Quant data, the three most recent Non Operating Interest Expenses figures were $21000.0 in Q4 2021, $20000.0 in Q3 2021, and $22000.0 in Q2 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Johnson & Johnson 641.14 Bn 620.38 Bn 17.26 Bn 281.00 Mn
2 AbbVie 451.04 Bn 444.47 Bn 12.70 Bn -
3 Merck 357.43 Bn 350.29 Bn 12.21 Bn -
4 Novartis Ag 266.73 Bn 259.04 Bn 11.24 Bn -462.00 Mn
5 Pfizer 157.52 Bn 145.82 Bn 10.94 Bn -
6 Sanofi 52.14 Bn 44.76 Bn 10.79 Bn -333.60 Mn
7 Revolution Medicines 42.88 Bn 42.88 Bn - 23.78 Mn
8 Incyte 24.70 Bn 20.16 Bn 1.57 Bn 582,000.00
9 United Therapeutics 21.47 Bn 18.80 Bn 683.80 Mn 2.90 Mn
10 BeyondSpring 31.51 Mn 31.51 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 21,000.00
Sep 30, 2021 20,000.00
Jun 30, 2021 22,000.00
Mar 31, 2021 24,000.00
Dec 31, 2020 22,000.00
Sep 30, 2020 21,000.00
Jun 30, 2020 21,000.00
Mar 31, 2020 21,000.00
Dec 31, 2019 20,000.00
Sep 30, 2019 46,000.00
Jun 30, 2019 103,000.00
Mar 31, 2019 37,000.00